WE ARE ENHANCING THE SAFETY OF OUR PRODUCTS!
The pharmacovigilance system of esparma GmbH in Ukraine functions according to the current legislation of Ukraine – the Decree of the Health Ministry of Ukraine dated 27.12.2006 # 898 (amended by the Decree of the Health Ministry of Ukraine #996 as of 26.09.2016) and in accordance with international guidelines and standards.
The safety of our products and our patients is the top priority for esparma GmbH.
If you would like to report an adverse reaction and/or the lack of efficacy while using medicinal products of esparma GmbH, please contact pharmacovigilance specialists one of the following:
- Message from
- If you have additional questions, call:
0 800 300 789 (autoresponder); +38 067 568 68 95 (24-hour)